help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0737
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer-Posovszky, P.
Right arrow Articles by Wabitsch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer-Posovszky, P.
Right arrow Articles by Wabitsch, M.
Related Collections
Right arrow Autoimmunity
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 3 1129-1135
Copyright © 2006 by The Endocrine Society

Role of CD95-Mediated Adipocyte Loss in Autoimmune Lipodystrophy

Pamela Fischer-Posovszky, Helge Hebestreit, Albert K. Hofmann, Gudrun Strauss, Peter Möller, Klaus-Michael Debatin and Martin Wabitsch

Department of Pediatrics and Adolescent Medicine (P.F.-P., G.S., K.-M.D., M.W.), University of Ulm, D-89075 Ulm, Germany; University Children’s Hospital (H.H.), University of Würzburg, D-97080 Würzburg, Germany; Clinic for Plastic Surgery (A.K.H.), D-89073 Ulm, Germany; and Department of Pathology (P.M.), University of Ulm, D-89081 Ulm, Germany

Address all correspondence and requests for reprints to: Prof. Dr. Martin Wabitsch, Pediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, University of Ulm, Prittwitzstrasse 43, 89075 Ulm, Germany. E-mail: martin.wabitsch{at}medizin.uni-ulm.de.

Context: Lipodystrophies are rare disorders characterized by the selective loss of adipose tissue. Metabolic complications increase in severity with the extent of fat loss. In some forms of acquired lipodystrophy, the loss of fat is suggested to be a result of autoimmune destruction of adipocytes. Here, the pathogenic mechanism is still poorly understood.

Objective: We have analyzed sc adipose tissue from a 5-yr-old girl with ongoing fat loss by immunohistochemistry. Using cultured human preadipocytes and adipocytes, we elucidated a possible mechanism leading to adipocyte loss in this patient.

Results: Analysis of adipose tissue samples of the patient with acquired lipodystrophy obtained from skin areas affected by panniculitis suggested that loss of adipocytes was mediated by CD95-induced apoptosis. Regression of adipose tissue was accompanied by lymphohistiocytic infiltration/inflammation and increased serum levels of inflammatory cytokines interferon-{gamma} and TNF-{alpha}. In vitro studies with human adipocytes demonstrated that interferon-{gamma} and TNF-{alpha} are able to up-regulate CD95 expression and enhance CD95-death-inducing signaling complex formation resulting in a robust sensitization for CD95-mediated apoptosis.

Conclusion: We have identified here a possible mechanism responsible for the loss of adipocytes by apoptosis in autoimmune lipodystrophy.




eLetters:

Read all eLetters

Adipocyte and the complement system
Sujoy Khan, et al.
JCEM Online, 11 Jan 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society